This is an early phase study in patients with Tuberculosis (TB) to evaluate Fibroblast Activating Protein (FAP) activation as a marker of fibrosis. The Investi…

Tuberculosis, Pulmonary

~Estimated

~$10 – $6,250

University of PennsylvaniaNCT07830771

Biodistribution and Pathophysiology Study of 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

The investigators will assess the hypothesis is that 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) Positron emission tomography (PET) could be used…

Tuberculosis, Pulmonary

~Estimated

~$10 – $675

Children's Hospital Medical Center, CincinnatiNCT07077213